Navigation Links
Hepatitis B Vaccine Market Scenario (Global, China) Analyzed
Date:9/7/2015

PUNE, India, September 7, 2015 /PRNewswire/ --

2015 Hepatitis B Vaccine Market Report - Global and Chinese Industry Scenario is the latest (Aug 2015 publication) research on hepatitis B vaccine based on industry experts' analysis offering forecasts to 2020 for the global and China markets.

Complete report on hepatitis B vaccine market spread across 150 pages, analyzing and profiling 10 major companies and supported with 25+ tables and figures is now available at http://www.rnrmarketresearch.com/2015-hepatitis-b-vaccine-industry-report-global-and-chinese-market-scenario-market-report.html .

Delivery of 2015 hepatitis B vaccine market report will take 2-3 working days once order is placed. This is a professional and in-depth market survey on global and Chinese hepatitis B vaccine market that helps review the basic information of Hepatitis B Vaccine including its classification, application and manufacturing technology. The research explores global and China's top manufacturers of Hepatitis B Vaccine market, listing their product specification, capacity, Production value, and market share etc. The report further analyzes, quantitatively, 2010-2015 global and China's total market of Hepatitis B Vaccine by calculation of main economic parameters of each company.

The breakdown data and information of Hepatitis B Vaccine market is presented by company, by country, and by application in this report. It estimates 2015-2020 market development of Hepatitis B Vaccine Industry. The report then analyzes the upstream raw materials, downstream clients, and current dynamics of Hepatitis B Vaccine market. In the end, the report makes some proposals for a new project of Hepatitis B Vaccine market before evaluating its feasibility. Overall, the report provides an in-depth insight of 2010-2015 global and China Hepatitis B Vaccine market covering all important parameters.

With one chapter dedicated each to hepatitis B vaccine market manufacturers' profiles (10 in total) and 2015-2020 forecasts covering global and China capacity, production, and production value of hepatitis b vaccine, cost and profit estimation, market share, supply and consumption as well as China import and export of hepatitis B vaccine, this 2015 market report is available for purchase at http://www.rnrmarketresearch.com/contacts/purchase?rname=408616 .

On similar lines, another research titled Hepatitis B - Pipeline Review, H1 2015 provides comprehensive information on the therapeutic development for Hepatitis B, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis B and special features on late-stage and discontinued projects. Supported with 111 tables and 17 figures, this research provides a review of the Hepatitis B products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.  Read more at http://www.rnrmarketresearch.com/hepatitis-b-pipeline-review-h1-2015-market-report.html .

RnRMarketResearch.com offers multiple newly published and relevant research titles for the stakeholders and decision makers of hepatitis drugs market:

Hepatitis Drugs Markets in China: China's demand for Hepatitis Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants for hepatitis drugs market. Historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024 are presented. Major producers in China are profiled. The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars. Complete report is available at http://www.rnrmarketresearch.com/chinese-markets-for-hepatitis-drugs-market-report.html .

Global Travel Vaccines Market 2015-2019: Based on composition, the Global Travel Vaccines market is divided into two segments: Mono Vaccines and Combination Vaccines. To calculate the market size, the report considers revenue generated through the sale of various vaccines administered to actively immunize against meningococcal disease, Japanese encephalitis, rabies, typhoid, yellow fever, hepatitis B, and hepatitis A. Analysts forecast the Global Travel Vaccines market to grow at a CAGR of 7.78% over the period 2014-2019. Companies like GlaxoSmithKline, Merck & Co., Novartis, Sanofi, Beijing Minhai Biotechnology, Bharat Biotech, Bio Med, Crucell, CSL, Dynavax Technologies, Emergent Biosolutions, Green Signal Bio Pharma, Hualan Biological Engineering, Imunoloski Zavod, Indian Immunologicals, Janssen Pharmaceuticals, JN International Medical, Kaketsuken, LG Life Sciences, Novavax, Nuron Biotech, Panacea Biotec, Pfizer, S K Chemicals, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, Vacunas Finlay and Valneva are mentioned in this research available at http://www.rnrmarketresearch.com/global-travel-vaccines-market-2015-2019-market-report.html .

Explore more reports on pharmaceuticals market at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals .

About Us:  

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us: 

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

RSS / Feeds: http://www.rnrmarketresearch.com/feed

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@rnrmarketresearch.com



'/>"/>
SOURCE RnR Market Research
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus
2. The Lancet Infectious Diseases Journal Publishes Results of Phase 2 Study of Lonafarnib in Hepatitis Delta Virus (HDV) Infected Patients
3. New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State
4. AbbVie Announces New Phase 3b Results in Genotype 1b Chronic Hepatitis C Patients with Compensated Liver Cirrhosis
5. Burmans Specialty Pharmacy study shows hepatitis C cure possible while cutting a third of the drug costs
6. Diplomat expands hepatitis C specialty services with acquisition of Burmans Specialty Pharmacy
7. AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis
8. 2015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research
9. Benitec Biopharma Doses Fifth Patient And Initiates Additional Trial Site For Hepatitis C Trial
10. Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV)
11. U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2019)... ... August 19, 2019 , ... Transformations ... Annual National Sports Summit, August 25-26 at the Hyatt Place in Delray Beach, ... all major professional sports programs to discuss progress made over the last year ...
(Date:8/19/2019)... , ... August 18, 2019 , ... Laurence Fishburne is ... ages across the globe. His work spans genres and generations. On television, he has ... series that covers topics important to today's world and gives viewers information in a ...
(Date:8/17/2019)... ... 2019 , ... The American Legion Dorchester Post 91 in Cambridge, Md., donated ... the benefit of veteran patients, adding to a donation in the same amount it ... most recent donation from Post 91 will enable the VA Maryland Health Care System ...
Breaking Medicine Technology:
(Date:8/19/2019)... ... August 19, 2019 , ... ProRehab Louisville and Dr. Stacie Grossfeld have ... and to access to top-notch sports medical care and sport injury experts for rehabilitation. ... demands of ice skating, knows the individualized treatment plan, and understands what a triple ...
(Date:8/19/2019)... ... 19, 2019 , ... Cosmetic Town, an online plastic surgery and information community ... in New York currently providing a lifetime of natural looking results for patients with ... hair. Cosmetic Town makes the process of finding information about these board-certified surgeons in ...
(Date:8/17/2019)... Fla. (PRWEB) , ... August 17, 2019 , ... ... Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000 , For the 2nd ... 2098 With Three-Year Revenue Growth of 192% Percent , Inc. magazine today revealed ...
(Date:8/16/2019)... ... 16, 2019 , ... The clinical trial supply chain landscape is constantly shifting, ... Join Just In Time Manufacturing Solutions Manager at Almac Clinical Services , Natalie ... EDT (4pm BST/UK) on a journey through time as it relates to clinical trial ...
(Date:8/16/2019)... ... August 16, 2019 , ... Dr. Demetri ... the esteemed Haute Beauty Network. , The Haute Beauty Network, well known for ... Arnaoutakis as a hair restoration expert and our newest addition to the Haute ...
Breaking Medicine News(10 mins):